Search Results - "JANKUS, D. D"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis by JOHNSON, J. L, HADAD, D. J, PALACI, M, DIETZE, R, BOOM, W. H, DALEY, C. L, PELOQUIN, C. A, EISENACH, K. D, JANKUS, D. D, DEBANNE, S. M, CHARLEBOIS, E. D, MACIEL, E

    “…OBJECTIVE: To evaluate the early bactericidal activity (EBA) of the new fluoroquinolones levofloxacin, gatifloxacin and moxifloxacin in patients with pulmonary…”
    Get full text
    Journal Article
  2. 2

    Abstract P1-16-04: First-line chemotherapy for breast cancer patients by site of care (SOC): Treatment patterns, cost and quality indicators by Masaquel, A, Hopson, S, Casebeer, A, Drzayich-Jankus, D, Tao, Z, Stemkowski, S, Howe, A, Patton, J, Small, A, Barnett, B

    Published in Cancer research (Chicago, Ill.) (15-02-2016)
    “…Abstract Background: Previous studies found differences in treatment patterns and costs by SOC for first-line chemotherapy treatment for both early stage and…”
    Get full text
    Journal Article
  3. 3

    Randomized Trial of Adjunctive Interleukin-2 in Adults with Pulmonary Tuberculosis by Johnson, John L, Ssekasanvu, Emmanuel, Okwera, Alphonse, Mayanja, Harriet, Hirsch, Christina S, Nakibali, Joseph G, Jankus, Dana Drzayich, Eisenach, Kathleen D, Boom, W. Henry, Ellner, Jerrold J, Mugerwa, Roy D

    “…Interleukin (IL)-2 has a central role in regulating T cell responses to Mycobacterium tuberculosis. Adjunctive immunotherapy with recombinant human IL-2 was…”
    Get full text
    Journal Article